Shares of CompuGroup Medical Societas Europaea (ETR:COP) have been given an average recommendation of “Buy” by the six brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is €57.33 ($66.67).

COP has been the subject of a number of research reports. Berenberg Bank set a €53.00 ($61.63) price target on shares of CompuGroup Medical Societas Europaea and gave the stock a “neutral” rating in a research report on Tuesday, September 19th. HSBC Holdings plc set a €61.00 ($70.93) price target on shares of CompuGroup Medical Societas Europaea and gave the stock a “buy” rating in a research report on Wednesday, October 18th. Deutsche Bank AG set a €60.00 ($69.77) price target on shares of CompuGroup Medical Societas Europaea and gave the stock a “buy” rating in a research report on Monday, October 16th. Baader Bank set a €52.00 ($60.47) price target on shares of CompuGroup Medical Societas Europaea and gave the stock a “neutral” rating in a research report on Wednesday, September 20th. Finally, Warburg Research set a €52.00 ($60.47) price target on shares of CompuGroup Medical Societas Europaea and gave the stock a “neutral” rating in a research report on Thursday, August 3rd.

Shares of CompuGroup Medical Societas Europaea (ETR:COP) traded up €3.90 ($4.53) during trading on Monday, reaching €51.86 ($60.30). 271,278 shares of the company were exchanged, compared to its average volume of 50,023. CompuGroup Medical Societas Europaea has a 12-month low of €36.06 ($41.93) and a 12-month high of €52.94 ($61.56).

WARNING: This piece was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/11/13/compugroup-medical-societas-europaea-cop-receives-consensus-rating-of-buy-from-brokerages.html.

CompuGroup Medical Societas Europaea Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for CompuGroup Medical Societas Europaea (ETR:COP)

Receive News & Ratings for CompuGroup Medical Societas Europaea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuGroup Medical Societas Europaea and related companies with MarketBeat.com's FREE daily email newsletter.